Do You Smell Trouble? Understanding the Impact of Chronic Rhinosinusitis with Nasal Polyps on Patients and Guideline Recommendations to Optimize Care

This webinar was recorded on May 10, 2023
Sponsored by GSK 

Chronic rhinosinusitis with nasal polyps (CRSwNP) affects approximately 2-4% of adults in the US. The predominant subtype is eosinophilic CRSwNP, which occurs in approximately 90% of cases. Common symptoms include nasal obstruction, rhinorrhea, reduction or loss of smell, and fatigue. Comorbidities such as asthma are common in patients with CRSwNP. Management of CRSwNP includes pharmacological and surgical options. This program will provide disease education for population-based decision-makers to enhance understanding of CRSwNP and support appropriate medical management.

The program will review:

• Clinical manifestations and disease course of patients with CRSwNP.
• Clinical and economic burden of patients with this condition.
• Guideline recommendations for the management of CRSwNP, including appropriate patient type for biologic therapy.

At the end of the program, attendees should be able to:

• Understand the prevalence, clinical characteristics, and associated comorbidities of CRSwNP.
• Describe the etiology and pathogenesis of CRSwNP.
• Understand the impact of CRSwNP on patients.
• Discuss the current guidelines for treatment and management considerations of patients with CRSwNP.

Speaker:

Jared Silver, MD, PhD
GSK
US Medical Affairs, Respiratory Therapeutic Area

This webinar is sponsored, developed, and presented by the sponsor.  The content of this Science & Innovation Webinar and opinions expressed by the presenters are those of the sponsor or presenters and not of AMCP.

Sponsored by: